Kilpirauhasen vajaatoiminta, näytönastekatsausten kirjallisuusviitteet

Kirjallisuutta

1. Akirov A, Fazelzad R, Ezzat S, ym. A Systematic Review and Meta-Analysis of Patient Preferences for Combination Thyroid Hormone Treatment for Hypothyroidism. Front Endocrinol (Lausanne) 2019;10():477 «PMID: 31396154»PubMed
2. Appelhof BC, Fliers E, Wekking EM, ym. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 2005;90(5):2666-74 «PMID: 15705921»PubMed
3. Biondi B, Wartofsky L. Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J Clin Endocrinol Metab 2012;97(7):2256-71 «PMID: 22593590»PubMed
4. Brandt F, Green A, Hegedüs L, ym. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. Eur J Endocrinol 2011;165(4):491-7 «PMID: 21724839»PubMed
5. Bunevicius R, Jakuboniene N, Jurkevicius R, ym. Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease. Endocrine 2002;18(2):129-33 «PMID: 12374459»PubMed
6. Bunevicius R, Prange AJ. Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism. Int J Neuropsychopharmacol 2000;3(2):167-174 «PMID: 11343593»PubMed
7. Clyde PW, Harari AE, Getka EJ, ym. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA 2003;290(22):2952-8 «PMID: 14665656»PubMed
8. Collet TH, Gussekloo J, Bauer DC, ym. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012;172(10):799-809 «PMID: 22529182»PubMed
9. Eliakim A, Barzilai M, Wolach B, ym. Should we treat elevated thyroid stimulating hormone levels in obese children and adolescents? Int J Pediatr Obes 2006;1(4):217-21 «PMID: 17907328»PubMed
10. Escobar-Morreale HF, Botella-Carretero JI, Escobar del Rey F, ym. REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab 2005;90(8):4946-54 «PMID: 15928247»PubMed
11. Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, ym. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med 2005;142(6):412-24 «PMID: 15767619»PubMed
12. Fadeyev VV, Morgunova TB, Melnichenko GA, ym. Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism. Hormones (Athens) 2010;9(3):245-52 «PMID: 20688622»PubMed
13. Fischman A, Domínguez JM. Combined therapy with levothyroxine and liothyronine for hypothyroidism. Medwave 2018;18(8):e7376 «PMID: 30550536»PubMed
14. Grozinsky-Glasberg S, Fraser A, Nahshoni E, ym. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2006;91(7):2592-9 «PMID: 16670166»PubMed
15. Hoang TD, Olsen CH, Mai VQ, ym. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab 2013;98(5):1982-90 «PMID: 23539727»PubMed
16. Joffe RT, Brimacombe M, Levitt AJ, ym. Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: a literature review and metaanalysis. Psychosomatics 2007;48(5):379-84 «PMID: 17878495»PubMed
17. Jonklaas J, Bianco AC, Cappola AR, ym. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document. Thyroid 2021;31(2):156-182 «PMID: 33276704»PubMed
18. Jonklaas J, Burman KD. Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters. Thyroid 2016;26(6):770-8 «PMID: 27030088»PubMed
19. Jonklaas J. Optimal Thyroid Hormone Replacement. Endocr Rev 2022;43(2):366-404 «PMID: 34543420»PubMed
20. Kaminski J, Miasaki FY, Paz-Filho G, ym. Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study. Arch Endocrinol Metab 2016;60(6):562-572 «PMID: 27982198»PubMed
21. Karmisholt J, Andersen S, Laurberg P. Weight loss after therapy of hypothyroidism is mainly caused by excretion of excess body water associated with myxoedema. J Clin Endocrinol Metab 2011;96(1):E99-103 «PMID: 20926526»PubMed
22. Kong WM, Sheikh MH, Lumb PJ, ym. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med 2002;112(5):348-54 «PMID: 11904108»PubMed
23. Krysiak R, Marek B, Okopień B. Sexual function and depressive symptoms in young men with hypothyroidism receiving levothyroxine/liothyronine combination therapy. Endokrynol Pol 2018;69(1):16-22 «PMID: 29319127»PubMed
24. Krysiak R, Szkróbka W, Okopień B. Sexual function and depressive symptoms in young women with hypothyroidism receiving levothyroxine/liothyronine combination therapy: a pilot study. Curr Med Res Opin 2018;34(9):1579-1586 «PMID: 29508635»PubMed
25. Kumar S, Dayal D, Attri S, ym. Levothyroxine supplementation for obesity-associated thyroid dysfunction in children: a prospective, randomized, case control study. Pediatr Endocrinol Diabetes Metab 2019;25(3):107-113 «PMID: 31769268»PubMed
26. Lan H, Wen J, Mao Y, ym. Combined T4 + T3 therapy versus T4 monotherapy effect on psychological health in hypothyroidism: A systematic review and meta-analysis. Clin Endocrinol (Oxf) 2022;97(1):13-25 «PMID: 35445422»PubMed
27. Leese GP, Soto-Pedre E, Donnelly LA. Liothyronine use in a 17 year observational population-based study - the tears study. Clin Endocrinol (Oxf) 2016;85(6):918-925 «PMID: 26940864»PubMed
28. Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, ym. Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk. Eur J Endocrinol 2019;180(6):407-416 «PMID: 31035256»PubMed
29. Ma C, Xie J, Huang X, ym. Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism. Nucl Med Commun 2009;30(8):586-93 «PMID: 19491714»PubMed
30. Meier C, Staub JJ, Roth CB, ym. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001;86(10):4860-6 «PMID: 11600554»PubMed
31. Millan-Alanis JM, González-González JG, Flores-Rodríguez A, ym. Benefits and Harms of Levothyroxine/L-Triiodothyronine Versus Levothyroxine Monotherapy for Adult Patients with Hypothyroidism: Systematic Review and Meta-Analysis. Thyroid 2021;31(11):1613-1625 «PMID: 34340589»PubMed
32. Mooijaart SP, Du Puy RS, Stott DJ, ym. Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism. JAMA 2019;322(20):1977-1986 «PMID: 31664429»PubMed
33. Najafi L, Malek M, Hadian A, ym. Depressive symptoms in patients with subclinical hypothyroidism--the effect of treatment with levothyroxine: a double-blind randomized clinical trial. Endocr Res 2015;40(3):121-6 «PMID: 25775223»PubMed
34. Nygaard B. Hypothyroidism (primary). BMJ Clin Evid 2014;2014(): «PMID: 24807886»PubMed
35. Parle J, Roberts L, Wilson S, ym. A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study. J Clin Endocrinol Metab 2010;95(8):3623-32 «PMID: 20501682»PubMed
36. Perros P, Nirantharakumar K, Hegedüs L. Recent evidence sets therapeutic targets for levothyroxine-treated patients with primary hypothyroidism based on risk of death. Eur J Endocrinol 2021;184(2):C1-C3 «PMID: 33306038»PubMed
37. Razvi S, Ingoe L, Keeka G, ym. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab 2007;92(5):1715-23 «PMID: 17299073»PubMed
38. Regalbuto C, Maiorana R, Alagona C, ym. Effects of either LT4 monotherapy or LT4/LT3 combined therapy in patients totally thyroidectomized for thyroid cancer. Thyroid 2007;17(4):323-31 «PMID: 17465862»PubMed
39. Reuters VS, Almeida Cde P, Teixeira Pde F, ym. Effects of subclinical hypothyroidism treatment on psychiatric symptoms, muscular complaints, and quality of life. Arq Bras Endocrinol Metabol 2012;56(2):128-36 «PMID: 22584566»PubMed
40. Rodriguez T, Lavis VR, Meininger JC, ym. Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone. Endocr Pract 2005;11(4):223-33 «PMID: 16006298»PubMed
41. Saravanan P, Simmons DJ, Greenwood R, ym. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J Clin Endocrinol Metab 2005;90(2):805-12 «PMID: 15585551»PubMed
42. Sawka AM, Gerstein HC, Marriott MJ, ym. Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003;88(10):4551-5 «PMID: 14557420»PubMed
43. Shakir MKM, Brooks DI, McAninch EA, ym. Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism. J Clin Endocrinol Metab 2021;106(11):e4400-e4413 «PMID: 34185829»PubMed
44. Siegmund W, Spieker K, Weike AI, ym. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf) 2004;60(6):750-7 «PMID: 15163340»PubMed
45. Solter D, Solter M. Benefit of combined triiodothyronine (LT(3)) and thyroxine (LT(4)) treatment in athyreotic patients unresponsive to LT(4) alone. Exp Clin Endocrinol Diabetes 2012;120(2):121-3 «PMID: 22187290»PubMed
46. Somwaru LL, Arnold AM, Joshi N, ym. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab 2009;94(4):1342-5 «PMID: 19126628»PubMed
47. Stott DJ, Rodondi N, Kearney PM, ym. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med 2017;376(26):2534-2544 «PMID: 28402245»PubMed
48. Tariq A, Wert Y, Cheriyath P, ym. Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life. South Med J 2018;111(6):363-369 «PMID: 29863229»PubMed
49. Thayakaran R, Adderley NJ, Sainsbury C, ym. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ 2019;366():l4892 «PMID: 31481394»PubMed
50. Valizadeh M, Seyyed-Majidi MR, Hajibeigloo H, ym. Efficacy of combined levothyroxine and liothyronine as compared with levothyroxine monotherapy in primary hypothyroidism: a randomized controlled trial. Endocr Res 2009;34(3):80-9 «PMID: 19701833»PubMed
51. Villar HC, Saconato H, Valente O, ym. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev 2007;2007(3):CD003419 «PMID: 17636722»PubMed
52. Walsh JP, Shiels L, Lim EM, ym. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 2003;88(10):4543-50 «PMID: 14557419»PubMed